Zanubrutinib |
泽布替尼 |
1691249-45-2 |
Sotorasib |
AMG510 单一构型 |
2296729-00-3 |
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- |
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- |
2160546-07-4 |
Phenyl N-(1-Methyl-1H-indol-5-yl) carbamate |
Phenyl N-(1-Methyl-1H-indol-5-yl) carbamate |
152239-62-8 |
2-AMino-6-chloro-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic Acid Ethyl Ester |
2-氨基-6-氯-ALPHA-氰基-3-(乙氧羰基)-4H-1-苯并吡喃-4-乙酸乙酯 |
305834-79-1 |
Leniolisib |
LENIOLISIB |
1354690-24-6 |
ACT-132577 |
N-[5-(4-溴苯基)-6-[2-[(5-溴-2-嘧啶基)氧基]乙氧基]-4-嘧啶基]氨基磺酰胺 |
1103522-45-7 |
Umbralisib |
TGR-1202 |
1532533-67-7 |
Birinapant |
非唑奈坦 |
1629229-37-3 |
SMURF1 inhibitor A01 |
SMURF1 inhibitor A01 |
1007647-73-5 |
OTS964 |
OTS964 |
1338545-07-5 |
2,4,7-trichloro-8-fluoropyrido[4,3-d]pyrimidine |
2,4,7-三氯-8-氟吡啶并[4,3-D]嘧啶 |
2454396-80-4 |
Pyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione, 7-chloro-8-fluoro- |
7-氯-8-氟吡啶并[4,3-D]嘧啶-2,4-二醇;7-氯-8-氟吡啶并[4,3-D]嘧啶-2,4(1H,3H)-二酮 |
2454397-75-0 |
LOXO-305 |
LOXO-305 |
2101700-15-4 |
1,3,2-Dioxaborolane, 2-[7-fluoro-3-(methoxymethoxy)-8-[2-[tris(1-methylethyl)silyl]ethynyl]-1-naphthalenyl]-4,4,5,5-tetramethyl- |
((2-氟-6-(甲氧基甲氧基)-8-(4,4,5,5-四甲基-1,3,2-二氧杂硼硼烷-2-基)萘-1-基)乙炔基)三异丙基硅烷 |
2621932-37-2 |
2-Propen-1-one, 1-[6-[(4R)-4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methyl-1H-indazol-5-yl)-1H-pyrazol-1-yl]-2-azaspiro[3.3]hept-2-yl]- |
JDQ-443 |
2653994-08-0 |
JAK1-IN-7 |
JAK1-IN-7 |
2241039-81-4 |
MRTX1133 |
MRTX1133 |
2621928-55-8 |
GLP-1 receptor agonist 1 |
GLP-1 receptor agonist 1 |
2212020-52-3 |
BLU-945 |
蓝-945 |
2660250-10-0 |